Get started

AZN

NVAX STOCKS DUMPED, DOWNTREND CONTINUESEarlier this year there was the question : How do you invest in Coronavirus vaccine stocks? Now, we have the answer : YOU DONT. Chart looking bleak, and the support lines are weak. This could be due to a few reasons: - Lack of MAINSTREAM updates - NVAX actually has no other vaccines - Market volatility due to covid and elections - Investors are seeking less riskier gains and getting out of stocks that do not look promising Other than the above, we have seen strange behavior with stocks of companies in the race. A few examples: PFE Pfizer stock not responding to numerous huge injections from government REGN Regeneron stocks hardly responding to Trump pimp GILD Gilead even FALLING after being the first company world wide to receive FDA approval for remdesivir as a treatment. AZN Astrazeneca in conjunction with Oxford has a trail candidate dead but stocks remain largely unaffected I think NVAX has potential in the long run, long term I remain bullish for the company fundamentally, but not for an investment choice right now. In fact I'd say that no vaccine stock is a good investment right now. The way the market reacts to news is too unpredictable and the future remains uncertain. Hit like if you found this insightful and helpful Thanks, Ev
NASDAQ:NVAX
by BlockTechEv
1
LONG $DGX ER run up ($MRNA $GILD $INO $SPY)see charts at www.tradingview.com $DGX Entry 120 Target 1 $125 Target 2 $130 Why DGX? FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use With Covid wave 2 on the rise, this could be a huge player. www.prnewswire.com What is DGX? Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, United Kingdom, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
NYSE:DGXLong
by WallSt007
AZN (ASTRAZENECA) (Y20.P4.E1).TA on short termHi All, Astreznenca is one of the hopeful leading pharma to bring about a vaccine for this covid virus. Rumors or articles suggested that this company would likely be successful in doing so amongst a few attempting it. Big money is at play. In the past week, we have news that the vaccine did not pass certain tests which explains the sell off and a 6 month delay in trials. OBSERVATIONS: > Upward channel with a top off spurt spike and a sell off, potentially of the news of the delays; It could also be a deviation from the main channel which is over extended so pulling back to the mean, average range; > Weekly MACD cross over the Signal, bearish indication; > Many of the big tech companies are having a sell off on their shares as US dollar looking to go up in the short term.; > I have previous ATH as potential support on this correction wave; > Has confluence with the 21 Weekly EMA and fib level retracement as per chart below; > RSI still above the 50% range on the weekly and hence still bullish and trend intact. THOUGHTS: Likely to drop to the bottom of the channel to mid range of the channel in the short term> $50 with a nice bounce as we have additionally the 50 EMA and previous resistance at the 0.5 fib level. I'm still thinking it will test the bottom of the channel even 2 deviation of the channel represented by the blue dashed lines. What ever the news it is, its worth considering because if they are successful, their shares will skyrocket. Please give me a tick or like for this post. Regards, S.SAri Weekly chart; MONTHLY chart: Upward trend intact and likely another bounce of the monthly macd off the signal trace. or the support line
ALong
by ssari
2
Long and hold $GSK ($MRNA $GILD $INO $SPY $PFE $JNJ $MRK)see full chart at www.tradingview.com GSK Entry $39.70 Target 1 $42.45 Target 2 $45.50 Target 3 $48 stoploss 38.70 Why this play? There are 4 general approaches to the Covid vaccine. 1.A "killed" coronavirus that will get recognized as foreign matter in the blood. (Sinovac/Dynavax) 2.Coronavirus proteins themselves, produced industrially in outside cell cultures, which will be recognized as foreign matter in the blood. (GlaxoSmithKline/Sanofi, Novavax) 3.A different virus (human or ape adenovirus, measles, etc) that is engineered to include genetic components coding for the SARS-CoV-2 spike proteins, which causes the body to then produce them. (CanSino, Oxford, J&J, Merck/Themis) 4.DNA or RNA that will be taken up by cells and will cause them to make coronavirus proteins. (Moderna, Innovio, BioNTech/Pfizer) GSK is #2, there is only 1 other big company doing this approach and that is NVAX. We are betting on the fact that if they are successful, they could have super run like NVAX. What is GSk? www.gsk.com GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
NYSE:GSKLong
by WallSt007
Disposable Surgical Robotic Device - BIG News Coming 8/17/20Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body's vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. Microbot Medical to Share Current Results of a Feasibility Animal Study Utilizing the LIBERTY Robotic System Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics Conference HINGHAM, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- At the upcoming Needham Virtual Med Tech & Diagnostics Conference, being held on Monday, August 17, 2020, Microbot Medical Inc. (Nasdaq: MBOT), will provide initial results of a feasibility animal study performed using the Company’s LIBERTY Robotic System. finance.yahoo.com On 1/13/20, H.C. Wainwright maintained a Buy rating on MBOT and raised the price target from $12 to $26.00. I think this device could be a game changer. Disposable medical devices is where the future is going especially for sanitary reasons. Watch this stock Monday, 8/17/2020, it could run hard. I think the stock has been consolidating for a while and is coiling and ready to explode higher. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:MBOTLong
by HotCharts
LONG $AZN Covid wave 2 play ($MRNA $GILD $INO $SPY)see full chart at www.tradingview.com AZN Entry $54 area Target $57 stoploss 53 Why this play? Covid Vaccine stocks are hot right now, cases are rising = easy money. What is AZN? AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999.
A
by WallSt007